Market Place
Sourcing Support
Avilar: MTAC Protein Degrader Preclinical Data At AAI Meeting
01 May 2024 //
BUSINESSWIRE
Avilar Receives U.S. Patent for Novel Extracellular Protein Degraders
27 Nov 2023 //
BUSINESSWIRE
Avilar Therapeutics to Present New Data for ATAC Extracellular Protein Degraders
30 Oct 2023 //
BUSINESSWIRE
Avilar Therapeutics to Present at Upcoming Industry Conferences
19 Sep 2023 //
BUSINESSWIRE
Avilar Therapeutics to Present at the 2023 Wells Fargo Healthcare Conference
30 Aug 2023 //
BUSINESSWIRE
Avilar Increases Financing to $75M to Advance Pipeline of Protein Degraders
16 Feb 2023 //
BUSINESSWIRE
Sanofi, Astellas venture arms add cash to Avilar`s `ATAC` mission
16 Feb 2023 //
ENDPTS
Avilar Therapeutics Presents New In Vivo Non-Human Primate Data for ATACs
07 Nov 2022 //
BUSINESSWIRE
Avilar to Present In Vivo Non-Human Primate Data on ASGPR-Targeting (ATACs)
01 Nov 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.